Vanderbilt University / VICC — Nashville, Tennessee

Vanderbilt University / VICC is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt University / VICC has participated in 1 clinical trials.

Therapeutic areas: Esophageal Neoplasms, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer.

Sponsors: Leap Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University / VICC?

Vanderbilt University / VICC has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University / VICC conducted?

Vanderbilt University / VICC has 1 clinical trials on record. Their work covers Esophageal Neoplasms, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer.

Is Vanderbilt University / VICC accredited by Crixeo Clinical Trials?

Vanderbilt University / VICC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University / VICC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.